Areas of Expertise
  • Financing
  • Mergers & Acquisitions
  • Licensing
  • Corporate Governance
Contact Chris Lowe
Download vCard

Chris Lowe

Chris Lowe joined FLG in 2014, serves on the Firm’s Management Committee and was elected Co-Managing Partner in 2018. Chris has over 15 years of senior management experience as President, CBO and CFO of various private and public life sciences, medical technology, and technology companies.  Additionally, he has served as a member of the Board of Directors of both public and private companies, and has chaired their respective Audit Committees and Compensation Committees.  Chris helps companies succeed by assisting them with corporate and financial strategy, including early stage financing, successive fundraising and IPOs, public company advising and Wall Street communications, licensing transactions, M&A, restructurings and coaching at every level of the C-Suite.  In particular, he excels at helping companies navigate the challenges of accessing capital, M&A, licensing, restructurings and exits.

During his career as a C-level executive, Chris has successfully raised over $500M in private and public financings, completed over $1.0B in M&A transactions, negotiated over $300M in debt instruments for companies, and has overseen three SOX-404 implementations.  As VP and CAO, he drove a parallel M&A and IPO path resulting in the sale of Peninsula Pharmaceuticals to Johnson & Johnson for over $300M in 2005, including the design of a tax efficient spinout for assets which were undervalued by Johnson & Johnson.  As CFO of Asthmatx, a medical technology company, he actively drove strategic supply negotiations and led the parallel M&A and IPO process resulting in a $50M strategic investment from Olympus Medical and ultimately the sale of the company to Boston Scientific in a deal valued at approximately $400M.  As its Chief Financial Officer, he also took Anthera Pharmaceuticals, a pharmaceutical development company, public in 2010 during the height of the financial crisis, raising over $300M in both the private and public markets during his tenure.

Prior to joining FLG, Chris  recently served as a strategy, financial and management consultant to several public and private companies, assisting them with financings, market due diligence, Wall Street communications, and exits.

Chris earned his B.S. from California Polytechnic State University – San Luis Obispo, and a MBA from St Mary’s University.  Chris currently sits on the Board of Directors of the following public and private companies: Hansen Medical (NASDAQ: HNSN; 2006-present); Pacific Pharmaceuticals (private; 2010-present); and Career Closet (Non Profit; 2009-present).


“When I agreed to join Hansen Medical, I knew we faced a multitude of challenges that had to be promptly addressed. As we evaluated the capital needs and cost structure of the company, I needed a CFO who could be a balanced and trusted business partner.  I needed someone to ensure my strategy was being implemented effectively, essentially an extension of me. Chris Lowe, my FLG partner, was immediately effective in guiding our financing strategy and implementing our cost reduction plans. The success of these programs allowed us to then pursue a strategic sale.  Our achievements could not have been done without FLG’s support.”

CARY VANCE, CEO, HANSEN MEDICAL INC.


 



Chris's Perspective on FLG

FLG provides an unparalleled level of breadth and depth of expertise across many industries. The professional depth of the partnership makes each partner a better CFO which directly benefits our clients on a daily basis.

- Chris Lowe


Sector Experience
  • Biopharma
  • Diagnostics
  • Life Sciences
  • Medtech
Selected Engagements
Bioasis Technolodgies, Inc. Biopharma Permanent CFO Public
Inspyr Therapeutics, Inc. Biopharma CEO Public
Directorships
Asante Solutions Director
Pacific Pharmaceutical Services Healthcare ServicesLife Sciences Director Private
Hansen Medical, Inc. Life SciencesMedtech Director